Publications

Journal Article
Research Support, Non-U.S. Gov't
Ppublish 14 citations
Electronic publication date
September 8, 2001

View on Pubmed.gov 11466260 | View on doi.org 10.1136/bjo.85....

Gene transfer by viral vectors into blood vessels in a rat model of retinopathy of prematurity.

Search for publications in this journal Br J Ophthalmol - 85(8):991-5

Abstract

AIMS

To test the feasibility of gene transfer into hyaloid blood vessels and into preretinal neovascularisation in a rat model of retinopathy of prematurity (ROP), using different viral vectors.

METHODS

Newborn rats were exposed to alternating hypoxic and hyperoxic conditions in order to induce ocular neovascularisation (ROP rats). Adenovirus, herpes simplex, vaccinia, and retroviral (MuLV based) vectors, all carrying the beta galactosidase (beta-gal) gene, were injected intravitreally on postnatal day 18 (P18). Two sets of controls were also examined: P18 ROP rats injected with saline and P18 rats that were raised in room air before the viral vectors or saline were injected. Two days after injection, the rats were killed, eyes enucleated, and beta-gal expression was examined by X-gal staining in whole mounts and in histological sections.

RESULTS

Intravitreal injection of the adenovirus and vaccinia vectors yielded marked beta-gal expression in hyaloid blood vessels in the rat ROP model. Retinal expression of beta-gal with these vectors was limited almost exclusively to the vicinity of the injection site. Injection of herpes simplex yielded a punctuate pattern of beta-gal expression in the retina but not in blood vessels. No significant beta-gal expression occurred in rat eyes injected with the retroviral vector.

CONCLUSIONS

Adenovirus is an efficient vector for gene transfer into blood vessels in an animal model of ROP. This may be a first step towards utilising gene transfer as a tool for modulating ocular neovascularisation for experimental and therapeutic purposes.

References

Am J Pathol. 1997 Jul;151(1):281-91

Hum Gene Ther. 1996 May 1;7(7):799-808

Ophthalmic Res. 1997;29(5):242-51

Invest Ophthalmol Vis Sci. 1997 Oct;38(11):2224-33

Cited by 14 citations (total)

Journal Article Review

Retinopathy of prematurity: inflammation, choroidal degeneration, and novel promising therapeutic strategies.

Electronic publication date May 8, 2018

Search for publications in this journal J Neuroinflammation

José Carlos Rivera [...] Sylvain Chemtob et al.

Retinopathy of prematurity (ROP) is an important cause of childhood blindness globally, and the incidence is rising. The disease is...

Journal Article

Intraocular and systemic levels of vascular endothelial growth factor in advanced cases of retinopathy of prematurity.

Electronic publication date September 22, 2010

Search for publications in this journal Clin Ophthalmol

Raul Velez-Montoya [...] Hugo Quiroz-Mercado et al.

PURPOSE

To measure vitreous, aqueous, subretinal fluid and plasma levels of vascular endothelial growth factor in late stages of retinopathy of...

Conflict of interest statement

No conflict of interest statement provided.

MeSH

Specialties

Substances